BeStock  
Markets › Compare › MRVI vs AAPG

MRVI vs AAPG

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
MRVI · Maravai LifeSciences$6.98 ▼ 2.92%
AAPG · Ascentage Pharma$11.97 ▼ 3.78%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

2583141199257Nov 24, '25May 26, '26Nov 20, '26
  • MRVI +89.7%
  • AAPG -62.6%

Head to head

MetricMRVIAAPG
Price$6.98$11.97
Change today▼ 2.92%▼ 3.78%
Market cap$1.04B$1.12B
Return, 3 months-17.2%-28.4%
Return, year to date+114.8%-54.4%
Return, 1 year+86.1%-60.9%
P/E (TTM)––
P/B5.313.4
P/E percentile vs own 5y0th98th
Dividend yield––
Revenue growth (YoY, latest qtr)+10.1%-41.5%
Net profit growth (YoY)+46.7%-206.4%
Gross margin39.1%93.9%
Operating margin-25.6%-216.7%
Net margin-30.8%-228.5%
Return on equity-29.8%-240.3%
Analyst target vs. price+41.5%+250.9%
Analyst buy share100%100%
RSI (14)4329
30-day volatility80.7%64.7%
Max drawdown, 1 year-29.6%-65.1%
Trend readLeaning bearishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • AAPG is the largest of the group by market value.
  • MRVI has returned the most over the past year.
  • MRVI is growing revenue fastest.
  • MRVI keeps the most profit per dollar of sales.
  • AAPG has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top